{"id":41239,"date":"2023-11-20T00:50:33","date_gmt":"2023-11-20T06:50:33","guid":{"rendered":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/acrin-6698-pub-1\/"},"modified":"2023-11-20T00:50:33","modified_gmt":"2023-11-20T06:50:33","slug":"acrin-6698-pub-1","status":"publish","type":"tcia_citation","link":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/acrin-6698-pub-1\/","title":{"rendered":"ACRIN-6698-PUB-1"},"template":"","class_list":["post-41239","tcia_citation","type-tcia_citation","status-publish"],"tcia_citation_type":"Publication Citation","tcia_citation_text":"<p>Partridge, S. C., Zhang, Z., Newitt, D. C., Gibbs, J. E., Chenevert, T. L., Rosen, M. A., Bolan, P. J., Marques, H. S., Romanoff, J., Cimino, L., Joe, B. N., Umphrey, H. R., Ojeda-Fournier, H., Dogan, B., Oh, K., Abe, H., Drukteinis, J. S., Esserman, L. J., &amp; Hylton, N. M. (2018). <strong>Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial<\/strong>. Radiology, 289(3), 618\u2013627. <a href=\"https:\/\/doi.org\/10.1148\/radiol.2018180273\">https:\/\/doi.org\/10.1148\/radiol.2018180273<\/a><\/p>\n","tcia_citation_statement":"","tcia_citation_doi":"10.1148\/radiol.2018180273","_links":{"self":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations\/41239","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations"}],"about":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/types\/tcia_citation"}],"wp:attachment":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/media?parent=41239"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}